Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

84,399 results
Offices all Languages Stemming true Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K33/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 8,440
1.202024100973Formulierung und System zur Synthese von Chitosan-vermittelten Li 1.5 I Fe 1.5 III O 3 Nanokomposit
DE - 02.05.2024
Int.Class A61K 33/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
26Iron; Compounds thereof
 Appl.No 202024100973 Applicant Delekar Sagar Dadu Inventor

Eine Formulierung zur Synthese von Chitosan-vermittelten Li 1.5 I Fe 1.5 III O 3 Nanokompositen, umfassend: eine wirksame Menge Eisennitrat [ Fe( NO 3) 3 ·9H 2 O, 98.00 %]; eine wirksame Menge Lithiumnitrat [Li (NO 3) 2 6H 2 O, 99.99 %]; eine wirksame Menge Chitosan (CTS)-Biopolymer [(C6H 11 NO4)n , 90 % deacetyliert]; eine wirksame Menge Zitronensäure; eine wirksame Menge Salpetersäure; und eine wirksame Menge Ammoniumhydroxidlösung. embedded image

2.202024101011Eine Formulierung für superparamagnetische Eisenoxid-Nanopartikel für magnetische Hyperthermie-Behandlungsanwendungen
DE - 02.05.2024
Int.Class A61K 33/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
26Iron; Compounds thereof
 Appl.No 202024101011 Applicant Delekar Sagar Dadu Inventor

Eine Formulierung für superparamagnetische Eisenoxid-Nanopartikel (SPIONPs) zur Krebs-Nanotheranostik, bestehend aus: eine wirksame Menge Eisennitrat; eine wirksame Menge entionisiertes Wasser; eine wirksame Menge Ethylenglykol (EG) als Lösungsmittel; eine wirksame Menge Ammoniumhydroxid als Base; und eine wirksame Menge destilliertes Wasser. embedded image

3.WO/2024/087265PROTEIN INHIBITOR, REAGENT SET, AND USE THEREOF
WO - 02.05.2024
Int.Class A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
 Appl.No PCT/CN2022/131815 Applicant SOUTHERN MEDICAL UNIVERSITY Inventor SHI, Jian
A protein inhibitor, a reagent set, and a use thereof. The protein inhibitor is an inhibitor for inhibiting a CILK1 protein; the protein inhibitor is CILK1-C28 or CILK1-C30; the use of the protein inhibitor is to apply the protein inhibitor to the research of a CILK1 protein inhibition mechanism; the protein inhibitor inhibits the CILK1 protein, is beneficial to inhibiting cancer cells, and can be used in combination with chemotherapy drugs.
4.WO/2024/089410IMPLANTABLE MEDICAL DEVICES
WO - 02.05.2024
Int.Class A61L 31/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
31Materials for other surgical articles
04Macromolecular materials
06obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
 Appl.No PCT/GB2023/052775 Applicant CONVATEC LIMITED Inventor BOOTE, Nicholas David
An implantable medical device comprising a nitric oxide generating polymeric material, wherein (i) The nitric oxide generating polymeric material includes a polymer and: (a) particles, wherein one or more individual particles each contain a nitrite salt and a proton source; or (b) an agglomeration of particles, wherein the agglomeration includes one or more individual particles containing a nitrite salt, one or more individual particles containing a proton source and optionally a binding agent or the agglomeration of particles includes one or more individual particles that each contain a nitrite salt and a proton source and optionally a binding agent; (ii) The nitric oxide generating polymeric material includes a proton source polymer and the nitric oxide generating polymeric material includes a nitrite salt dissolved in the proton source polymer matrix; or (iii) Combinations of (i) and (ii) above.
5.20240139237METHODS AND COMPOSITIONS FOR WOUND HEALING
US - 02.05.2024
Int.Class A61K 33/38
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
38Silver; Compounds thereof
 Appl.No 18376044 Applicant Nicholas L. Abbott Inventor Nicholas L. Abbott

The present invention relates to large scale manufacture of nanoscale microsheets for use in applications such as wound healing or modification of a biological or medical surface.

6.WO/2024/092172HYDROGEN SULFIDE DELIVERY DEVICE
WO - 02.05.2024
Int.Class C01B 17/16
CCHEMISTRY; METALLURGY
01INORGANIC CHEMISTRY
BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF
17Sulfur; Compounds thereof
16Hydrogen sulfides
 Appl.No PCT/US2023/077974 Applicant EXHALIX LLC Inventor SHEKARRIZ, Alireza
A hydrogen sulfide generator includes an electrolytic cell. The cell includes first and counter-electrodes, an electrolyte and a solid-state hydrogen sulfide precursor in electrical connection with the first electrode. Upon applying a small potential across the cell, the hydrogen sulfide precursor generates hydrogen sulfide gas which permeates from the cell. The hydrogen sulfide generator is useful for delivering therapeutic levels of hydrogen sulfide to wounded tissue, and this is a useful component of a tissue dressing.
7.WO/2024/090537ZINC POLYPHOSPHATE AND METHOD FOR PRODUCING SAME
WO - 02.05.2024
Int.Class C01B 25/40
CCHEMISTRY; METALLURGY
01INORGANIC CHEMISTRY
BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF
25Phosphorus; Compounds thereof
16Oxyacids of phosphorus; Salts thereof
26Phosphates
38Condensed phosphates
40Polyphosphates
 Appl.No PCT/JP2023/038803 Applicant KAMUI PHARMA, INC. Inventor FUJIYA Mikihiro
The present invention relates to a novel zinc polyphosphate, a use thereof, and a method for producing the same. More specifically, the present invention relates to: a zinc polyphosphate which is characterized by showing a halo peak at 2θ=4° to 7° in X-ray diffraction; a pharmaceutical composition which contains said zinc polyphosphate as an active ingredient; and a method for producing zinc polyphosphate, the method comprising (1) a step of adding zinc ions to a polyphosphate solution under alkaline conditions, preferably at a pH of 8 to 11, and (2) a step of recovering, as zinc polyphosphate, a solid obtained in step (1).
8.WO/2024/090538PHARMACEUTICAL COMPOSITION CONTAINING ZINC POLYPHOSPHATE
WO - 02.05.2024
Int.Class A61K 33/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
30Zinc; Compounds thereof
 Appl.No PCT/JP2023/038804 Applicant KAMUI PHARMA, INC. Inventor FUJIYA Mikihiro
The present invention relates to a pharmaceutical composition for the treatment or prevention of inflammatory bowel diseases, said pharmaceutical composition containing zinc polyphosphate as an active ingredient. The zinc polyphosphate in the present invention has intestinal-canal-barrier enhancing activity and can treat or prevent inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.
9.WO/2024/091484SYNTHETIC AMNIOTIC FLUID COMPOSITIONS COMPRISING URINARY TRYPSIN INHIBITOR AND ASCORBIC ACID, AND METHODS OF USING SAME
WO - 02.05.2024
Int.Class A61K 38/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
55Protease inhibitors
57from animals; from humans
 Appl.No PCT/US2023/035776 Applicant CHILDERN'S HOSPITAL MEDICAL CENTER Inventor ORIA, Marc
Disclosed are synthetic amniotic fluid compositions comprising ulin-A- statin/urinary trypsin inhibitor (UTI) and ascorbic acid and methods of using the disclosed synthetic amniotic fluid compositions, which may be useful for a variety of purposes related to treatment of a fetus, replacement of amniotic fluid, or research uses in which amniotic cells or tissues are used. The synthetic amniotic fluid compositions may be used to minimize and/or reduce risks associated with currently utilized compositions for amnioinfusion, which traditionally include normal saline (NS) and Lactated Ringer's (LR), or to improve amniotic epithelial cell viability and integrity, in vivo and/or in vitro.
10.20240139080TOPICAL SKIN TREATMENT
US - 02.05.2024
Int.Class A61K 8/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
02characterised by special physical form
04Dispersions; Emulsions
 Appl.No 18461486 Applicant Kurt H. Ruppman Inventor Kurt H. Ruppman

In one aspect, the present disclosure relates to a composition comprising a mixture of: a nonessential amino acid; a collagen composition; a salt composition; zinc; potassium citrate; malic acid; vitamin C; potassium sorbate; caffeine; and water. In another aspect, the present disclosure relates to an aerosol mist formed subjecting the composition to electrolysis, ultrasonic vibration, or a combination thereof. In another aspect, the present disclosure relates to a method for treatment of skin disorders, joint pain, muscle pain, or a combination thereof, by topical application of the aerosol mist to an area of a human body proximate to one or more of skin disorders, joint pain, muscle pain, other ailments treatable through the epidermis skin layer, or a combination thereof.

# -